{{cart_num}}
My CartCAS：300-08-3
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 300-08-3 |
| Name | Arecoline Hydrobromide |
| Molecular Formula | C8H13NO2·HBr |
| Molecular Weight | 236.11 |
| Solubility | Soluble in Water/DMSO ≥10mg/mL；Soluble in Ethanol ≥5mg/mL |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 206-087-3 |
| MDL | MFCD00039041 |
| SMILES | O=C(C1=CCCN(C)C1)OC.Br |
| InChIKey | AXOJRQLKMVSHHZ-UHFFFAOYSA-N |
| InChI | InChI=1S/C8H13NO2.BrH/c1-9-5-3-4-7(6-9)8(10)11-2;/h4H,3,5-6H2,1-2H3;1H |
| PubChem CID | 9301 |
| Target Point | mAChR；nAChR |
| Passage | Neuronal Signaling;Membrane Transporter&Ion Channel |
| Background | Arecoline Hydrobromide is an alkaloid that is a partial agonist of the nicotinic and muscarinic acetylcholine receptors. Arecoline Hydrobromide can induce oxidative stress and has anti-anxiety and anti-parasitic activities. |
| Biological Activity | Arecoline, an arecanut alkaloid present in the saliva of betel quid chewers, has been implicated in the pathogenesis of a variety of inflammatory oral diseases, including oral submucous fibrosis and periodontitis.[1] A partial agonist of nicotinic and muscarinic acetylcholine receptors, arecoline evokes multiple effects on the central nervous system (CNS), including stimulation, alertness, elation, and anxiolysis. [2] |
| In Vitro | Arecoline induced the generation of reactive oxygen species and cell cycle arrest at the G1/G0 phase in HaCaT cells without affecting the expression of p21/Cip1. Arecoline-induced epithelial cell death at higher concentrations was caused by oxidative trauma without eliciting apoptosis. Sublethal concentrations of arecoline upregulated the expression of the following stress-responsive genes: heme oxygenase-1; ferritin light chain; glucose-6-phosphate dehydrogenase; glutamate-cysteine ligase catalytic subunit; and glutathione reductase. Additionally，there was a dose-dependent induction of interleukin-1alfa mRNA by arecoline via oxidative stress and p38 MAPK activation.[1] |
| Cell Experiment | Human keratinocyte cells(of the HaCaT cell line)were treated with arecoline，following which cell viability was assessed using the Trypan Blue dye-exclusion assay，cell growth and proliferation were analyzed using the MTT(3-[4，5-dimethylthiazol-2-yl]-2，5-diphenyltetrazolium bromide)and 5-bromo-2-deoxyuridine incorporation assays，cell cycle arrest and generation of reactive oxygen species were examined using flow cytometry，and gene expression changes were investigated using the reverse transcription-polymerase chain reaction technique.[1] |
| Data Literature Source | [1]. Thangjam GS，et，al. Regulation of oxidative-stress responsive genes by arecoline in human keratinocytes. J Periodontal Res. 2009 Oct;44(5):673-82. [2]. Volgin AD，et，al. DARK Classics in Chemical Neuroscience: Arecoline. ACS Chem Neurosci. 2019 May 15;10(5):2176-2185. |
| Unit | Bottle |
| Specification | 50mg 10mM*1mL in DMSO 100mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Manual Download
